Publikace
- In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites2015 | Farmaceutická fakulta v Hradci Králové
- Quantitative Analysis of the Anti-Proliferative Activity of Combinations of Selected Iron-Chelating Agents and Clinically Used Anti-Neoplastic Drugs2014 | Farmaceutická fakulta v Hradci Králové
- Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships2014 | Farmaceutická fakulta v Hradci Králové
- Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy2023 | 2. lékařská fakulta, Přírodovědecká fakulta
- Chimeric JAK2 Kinases Trigger Non-uniform Changes of Cellular Metabolism in BCR-ABL1-like Childhood ALL2023 | Ústřední knihovna, 2. lékařská fakulta
- Frequency and prognostic impact of ZEB2 H1038 and 1072 mutations in childhood B-other acute lymphoblastic leukemia2021 | 2. lékařská fakulta
- Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation2020 | 2. lékařská fakulta
- ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity2019 | 2. lékařská fakulta
- Two novel fusion genes, AIF1L-ETV6 and ABL1-AIF1L, result together with ETV6-ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin2018 | 2. lékařská fakulta, 3. lékařská fakulta
- Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative Activities2018 | Farmaceutická fakulta v Hradci Králové
Loading network view...